149 related articles for article (PubMed ID: 7718643)
1. Presenting signs and symptoms in multiple myeloma: high percentages of stage III among patients without apparent myeloma-associated symptoms.
Ong F; Hermans J; Noordijk EM; Wijermans PW; Kluin-Nelemans JC
Ann Hematol; 1995 Mar; 70(3):149-52. PubMed ID: 7718643
[TBL] [Abstract][Full Text] [Related]
2. Increased sialylation of oligosaccharides on IgG paraproteins--a potential new tumour marker in multiple myeloma.
Fleming SC; Smith S; Knowles D; Skillen A; Self CH
J Clin Pathol; 1998 Nov; 51(11):825-30. PubMed ID: 10193323
[TBL] [Abstract][Full Text] [Related]
3. Case of multiple myeloma mimicking an infectious disease with fever, intrahepatic cholestasis, renal failure, and pulmonary insufficiency.
Vella FS; Simone B; Giannelli G; Pesolo M; Ingravallo G; Gentile A; Antonaci S
Am J Hematol; 2003 Jan; 72(1):38-42. PubMed ID: 12508267
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma.
Tandon N; Rajkumar SV; LaPlant B; Pettinger A; Lacy MQ; Dispenzieri A; Buadi FK; Gertz MA; Hayman SR; Leung N; Go RS; Dingli D; Kapoor P; Lin Y; Hwa YL; Fonder AL; Hobbs MA; Zeldenrust SR; Lust JA; Gonsalves WI; Russell SJ; Kumar SK
Blood Cancer J; 2017 Feb; 7(2):e528. PubMed ID: 28211889
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lactate dehydrogenase in Chinese patients with newly diagnosed transplant eligible multiple myeloma.
Huang B; Lu J; Wang X; Xiao Y; Zhao Y; Huang H; Liu J; Chen M; Gu J; Yuan S; Zheng D; Li Y; Huang X; Li J
Leuk Lymphoma; 2017 Jul; 58(7):1740-1742. PubMed ID: 27881052
[No Abstract] [Full Text] [Related]
6. Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis.
Goldschmidt N; Zamir L; Poperno A; Kahan NR; Paltiel O
J Am Board Fam Med; 2016 Nov; 29(6):702-709. PubMed ID: 28076253
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of beta-catenin in multiple myeloma].
Li J; Zhang DB; Luo SK; Zhao Y; Huang BH; Gu JL
Ai Zheng; 2007 Sep; 26(9):1010-4. PubMed ID: 17927863
[TBL] [Abstract][Full Text] [Related]
9. Neoplasms of terminally differentiated B lymphocytes.
Holbert JM
Clin Lab Med; 1988 Mar; 8(1):197-210. PubMed ID: 3282759
[TBL] [Abstract][Full Text] [Related]
10. Anion gap among patients of multiple myeloma and normal individuals.
Mansoor S; Siddiqui I; Adil S; Nabi Kakepoto G; Fatmi Z; Ghani F
Clin Biochem; 2007 Feb; 40(3-4):226-9. PubMed ID: 17156769
[TBL] [Abstract][Full Text] [Related]
11. [Renal monoclonal immunoglobuline deposition disease as a rare variant of renal damage in multiple myeloma].
Gorchakova SV; Rekhtina IG; Iatskov KV; Sukhanova GA; Golitsina EP; Varshavskiĭ VA; Biriukova LS
Ter Arkh; 2009; 81(7):78-82. PubMed ID: 19708580
[TBL] [Abstract][Full Text] [Related]
12. [Light-chain myeloma and non-secretory myeloma--problems in di- agnosis and associated paraproteins].
Leinonen P; Somer T
Duodecim; 1988; 104(18):1466-70. PubMed ID: 3141128
[No Abstract] [Full Text] [Related]
13. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
[TBL] [Abstract][Full Text] [Related]
14. Paraprotein index: a simple prognostic parameter for multiple myeloma.
Pasqualetti P; Casale R; Colantonio D; Collacciani A
Am J Hematol; 1991 Aug; 37(4):284-5. PubMed ID: 1858790
[No Abstract] [Full Text] [Related]
15. Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.
Kasamatsu T; Ozaki S; Saitoh T; Konishi J; Sunami K; Itagaki M; Asaoku H; Cho T; Handa H; Hagiwara S; Wakayama T; Negoro A; Takezako N; Harada N; Kuroda Y; Nakaseko C; Miyake T; Inoue N; Hata H; Shimazaki C; Ohno T; Kuroda J; Murayama T; Kobayashi T; Abe M; Ishida T; Nagura E; Shimizu K
Hematol Oncol; 2018 Dec; 36(5):792-800. PubMed ID: 30176173
[TBL] [Abstract][Full Text] [Related]
16. [Biochemical and immunological findings of multiple myeloma].
Asaoku H
Nihon Rinsho; 2007 Dec; 65(12):2256-60. PubMed ID: 18069270
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical Diagnosis of Multiple Myeloma.
Lyubimova NV; Timofeev YS; Abaev VM; Votyakova OM; Kushlinskii NE
Bull Exp Biol Med; 2018 May; 165(1):84-87. PubMed ID: 29797132
[TBL] [Abstract][Full Text] [Related]
18. Revised International Staging System Applied to Real World Multiple Myeloma Patients.
Jimenez-Zepeda VH; Duggan P; Neri P; Rashid-Kolvear F; Tay J; Bahlis NJ
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):511-518. PubMed ID: 27425179
[TBL] [Abstract][Full Text] [Related]
19. MUSCULOSKELETAL PRESENTATION OF MULTIPLE MYELOMA AT GENERAL HOSPITAL DOUALA, CAMEROON.
Doualla-Bija M; Ndongho EN; Oben DT; Namme HL; Mbanya D
East Afr Med J; 2014 Sep; 91(9):311-6. PubMed ID: 26866083
[TBL] [Abstract][Full Text] [Related]
20. Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics.
Rifkin RM; Abonour R; Terebelo H; Shah JJ; Gasparetto C; Hardin J; Srinivasan S; Ricafort R; Nagarwala Y; Durie BG
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):368-76. PubMed ID: 25617035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
